GEM-X Universal 5' Gene Expression v3, 16 Samples
SAM.GOV Due: May 20, 2025 at 09:00 PM UTC
In-Active Combined Synopsis/Solicitation Source Url

Summary

The opportunity involves the procurement of GEM-X Universal 5' Gene Expression v3 reagents for the National Institutes of Health (NIH), specifically for the National Institute of Allergy and Infectious Diseases (NIAID). This acquisition is critical for ongoing clinical trials, particularly for isolating PBMCs and sorting plasmablasts for single-cell sequencing. The contractor must provide specific brand-name reagents from 10X Genomics to ensure consistency and reliability in research methodologies. Businesses with experience in biological product manufacturing and those capable of meeting the stringent requirements of clinical research should consider bidding on this opportunity.
Description

This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commerci

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
325414
Set Aside
None
Place of Performance
Bethesda , Maryland 20892
Point of Contact
Full Name Email Phone Type
RITA DAVIS [email protected] 3017617461 primary
Tonia Alexander [email protected] 2406695124 secondary
Attachments
  • RFQ-NIAID-25-2260513_Terms_and_Conditions_FAR_52.212-5.pdf